LV
LVGI.US Limitless Venture
- Market cap
- USD 317K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is LVGI.US undervalued?
Graham numberThe Graham number of Limitless Venture cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Limitless Venture fundamental analysis
No fundamental analysis for Limitless Venture yet.
Limitless Venture stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Limitless Venture
Limitless Venture Group Inc., a development stage company, produces, distributes, and markets body care, health, and alcoholic products. The company offers LIMITLESS BODY products, including BODY FRESH, a body wash; MUSCLE BUTTER, a body soothing massage butter; BODY SUGAR, a sugar body scrub; BARE SKIN, a moisturizing shave cream; and GYM SANI-T, a sanitizer. It also provides LIMITLESS HEALTH products, such as Prostaderol, a natural prostate health supplement; LipiRestorin;…
Full company profileLimitless Venture financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Limitless Venture annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 17.6K | 12.6K | - | 47.3K | 539K | 1.59M | 1.35M | 1.72M | 391K | - | - |
| Gross Profit | 6.76K | 1.14K | -27.0K | 35.1K | 182K | 572K | 608K | 980K | -146K | - | - |
| Operating Income | -40.9K | -11.8K | -38.9K | -328K | -885K | -1.18M | -772K | -425K | -442K | -47.3K | -32.4K |
| EBITDA | -40.9K | 514K | -11.9K | -316K | -984K | -1.04M | -1.47M | 522K | -497K | -47.3K | -32.4K |
| Net Income | -162K | 398K | 953K | -324K | -932K | -1.54M | -1.83M | -260K | -1.24M | -644K | -689K |
| EPS | -0.01 | 0.03 | 0.07 | -0.03 | -0.07 | -0.09 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 43.0K | 33.2K | 229.00 | 718K | 2.49M | 2.63M | 1.69M | 2.21M | 331K | 313K | 313K |
| Total Liabilities | 2.84M | 2.43M | 1.11M | 1.86M | 4.56M | 6.62M | 6.79M | 7.13M | 6.21M | 6.77M | 6.94M |
| Shareholders' Equity | -2.80M | -2.40M | -1.11M | -1.14M | -1.16M | -2.67M | -3.99M | -3.50M | -5.88M | -6.45M | -6.63M |
| Cash & Short-term Investments | 16.1K | 506.00 | 229.00 | 34.2K | 399K | 120K | 21.3K | 81.4K | 140K | 120K | 120K |
| Total Debt | 981K | 981K | 551K | 1.05M | 2.02M | 2.75M | 2.92M | 3.16M | 1.78M | 1.81M | 1.81M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -7.79K | -17.4K | -6.19K | -117K | -450K | -515K | -858K | 45.4K | -103K | -24.4K | - |
| Capital Expenditure | 550.00 | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 3.00 | 3.00 | - |
| Free Cash Flow | -8.34K | -17.5K | -6.19K | -117K | -450K | -515K | -858K | 45.4K | -103K | -24.4K | - |
| Ratios | |||||||||||
| ROA | -375.4% | 1,199.1% | 416,152.4% | -45.1% | -37.5% | -58.4% | -108.4% | -11.8% | -373.4% | -205.9% | -220.3% |
| Net Profit Margin | -918.5% | 3,167.1% | - | -684.3% | -172.8% | -96.9% | -135.3% | -15.2% | -316.2% | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Limitless Venture dividends
Limitless Venture has not paid dividends in the last 10 fiscal years.
Last stock split: 1:300 on Jul 9, 2020.
Who owns Limitless Venture
Ownership data of Limitless Venture is not available yet.
Limitless Venture company profile
- Company name
- Limitless Venture
- Ticker
- LVGI.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 2
- Fiscal year end
- December
- Address
- 121 East 35th Street, Tulsa, OK, United States, 74105
- Phone
- 918-671-9935
- Website
- lvginc.com
About Limitless Venture
Limitless Venture Group Inc., a development stage company, produces, distributes, and markets body care, health, and alcoholic products. The company offers LIMITLESS BODY products, including BODY FRESH, a body wash; MUSCLE BUTTER, a body soothing massage butter; BODY SUGAR, a sugar body scrub; BARE SKIN, a moisturizing shave cream; and GYM SANI-T, a sanitizer. It also provides LIMITLESS HEALTH products, such as Prostaderol, a natural prostate health supplement; LipiRestorin; and Maxtlevelin, a product to increase testosterone levels. In addition, the company offers HempCore health products comprising RELAX, an anxiety relief formula; FIBER UP to remove toxins; HEALTHY HEART, a product that promotes cardiovascular health and helps maintain healthy cholesterol levels; BRAIN BOOST, a neurotransmitter boosting formula that assists central nervous system to deliver oxygen and nutrients to the brain; and JOINT RELEIF, an anti-inflammation joint formula used to rebuild, lubricate, and soothe aching joints. Further, it provides ready to drink alcoholic shots that include Haymaker, a vodka with lemon and tea flavors; CoCo-Puff, a vodka with chocolate and Irish cream flavors; Red Headed Slut, a vodka with peach, licorice, and cranberry flavors; Twist, a tequila with lime flavor; and Kamikaze, a vodka with orange liquor and lime flavors. The company was formerly known as Enerbrite Technologies Group Inc. and changed its name to Limitless Venture Group Inc. in February 2013. Limitless Venture Group Inc. is based in Tulsa, Oklahoma.
Limitless Venture management
2- Mr. Joseph FrancellaChairman, President & CEO
- Mr. Devon Diaz P.E.Chief Operating Officer